The 53 rating InvestorsObserver gives to Fate Therapeutics Inc (FATE) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 55 percent of stocks in the Biotechnology industry, FATE’s 53 overall rating means the stock scores better than 53 percent of all stocks.
FATE has an Overall Score of 53. Find out what this means to you and get the rest of the rankings on FATE!